Paper5776003
Bacteriologic studies of rifampin, a new semisynthetic antibiotic.
Kunin CM and 2 others. J Infect Dis, 1969. Cited by 81 papers, by iCite.
Cite this record
ConductScience Library. Bacteriologic studies of rifampin, a new semisynthetic antibiotic. Papers, record 5776003. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5776003
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Bacteria | Major topic |
| Adult | |
| Chemical Phenomena | |
| Chemistry | |
| Drug Resistance, Microbial | |
| Enterobacteriaceae | |
| Humans | |
| Male | |
| Staphylococcus | |
| Streptococcus |
Source PubMed
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 81 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41545350 | Enzymes-enhanced antibiotic therapy reduces biofilms to undetectable levels in an implant-associated infection model. | NPJ Biofilms Microbiomes | 2026 | https://conductscience.org/library/papers/41545350 | PubMed |
| 20065324 | Rifampin combination therapy for nonmycobacterial infections. | Clin Microbiol Rev | 2010 | https://conductscience.org/library/papers/20065324 | PubMed |
| 16495239 | In vitro activity of novel rifamycins against rifamycin-resistant Staphylococcus aureus. | Antimicrob Agents Chemother | 2006 | https://conductscience.org/library/papers/16495239 | PubMed |
| 7325636 | Characteristics of rifampin-resistant variants obtained from clinical isolates of Staphylococcus aureus. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/7325636 | PubMed |
| 7113198 | Staphylococcal pericarditis-successful nonsurgical treatment with indwelling catheter and antibiotic drugs. | West J Med | 1982 | https://conductscience.org/library/papers/7113198 | PubMed |
| 6980623 | Emergence of rifampin-resistant Haemophilus influenzae. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6980623 | PubMed |
| 6910479 | Combination of minocycline and rifampicin against methicillin- and gentamicin-resistant Staphylococcus aureus. | J Clin Pathol | 1981 | https://conductscience.org/library/papers/6910479 | PubMed |
| 6901593 | Treatment of experimental staphylococcal infections: effect of rifampin alone and in combination on development of rifampin resistance. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6901593 | PubMed |
| 6859835 | In vitro activity of rifampin in combination with oxacillin against Staphylococcus aureus. | Antimicrob Agents Chemother | 1983 | https://conductscience.org/library/papers/6859835 | PubMed |
| 6732212 | Effect of rifampin and bacitracin on nasal carriers of Staphylococcus aureus. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6732212 | PubMed |
| 5001420 | Actions of the rifamycins. | Bacteriol Rev | 1971 | https://conductscience.org/library/papers/5001420 | PubMed |
| 4999067 | Clinical uses and control of rifampicin and clindamycin. | J Clin Pathol | 1971 | https://conductscience.org/library/papers/4999067 | PubMed |
| 4949280 | Rifampicin: a review. | Drugs | 1971 | https://conductscience.org/library/papers/4949280 | PubMed |
| 4943582 | Rifampin-blood-agar as a selective medium for the isolation of certain anaerobic bacteria. | Appl Microbiol | 1971 | https://conductscience.org/library/papers/4943582 | PubMed |
| 4790559 | Treatment of experimental staphylococcal infection with rifampin. | Antimicrob Agents Chemother | 1972 | https://conductscience.org/library/papers/4790559 | PubMed |
| 1137380 | Effect of rifampin on nasal carriage of Staphylococcus aureus. | Antimicrob Agents Chemother | 1975 | https://conductscience.org/library/papers/1137380 | PubMed |
| 1041216 | BL-P1654: a bacteriostatic penicillin? | Antimicrob Agents Chemother | 1975 | https://conductscience.org/library/papers/1041216 | PubMed |
| 666300 | In vitro activity of rifampin alone and in combination with nafcillin and Vancomycin against pathogenic strains of Staphylococcus aureus. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/666300 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/5776003
GET https://conductscience.org/api/papers/v1/5776003/authors